| Trial ID: | L2968 |
| Source ID: | NCT00106704
|
| Associated Drug: |
Comparator: Sitagliptin
|
| Title: |
Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00106704/results
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Comparator: Sitagliptin|DRUG: Comparator: Placebo|DRUG: Comparator: Pioglitazone
|
| Outcome Measures: |
Primary: Change From Baseline in A1C at Week 24, Hemoglobin A1C (A1C) is measured as percent. Thus this change from baseline reflects the Week 24 A1C percent minus the Week 0 A1C percent., Baseline and 24 Weeks | Secondary: Change From Baseline in FPG at Week 24, The change from baseline is the Week 24 Fasting Plasma Glucose (FPG) minus the Week 0 FPG., Baseline and 24 Weeks
|
| Sponsor/Collaborators: |
Sponsor: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
441
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-03
|
| Completion Date: |
2007-01
|
| Results First Posted: |
2010-12-17
|
| Last Update Posted: |
2015-07-01
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00106704
|
